For researchers at the forefront of oncology and signal transduction, sourcing high-purity MET kinase inhibitors is paramount. The compound identified by CAS number 1025720-94-8 stands out for its potent and selective inhibition of the MET kinase family, making it an indispensable tool for advancing drug discovery and understanding complex biological pathways.
As a key player in the pharmaceutical intermediate market, understanding the nuances of procuring such critical reagents is essential. This article delves into why selecting a reliable manufacturer and supplier, particularly one based in China, can be advantageous for acquiring these specialized compounds.
The Significance of MET Kinase Inhibitors in Research
The MET receptor tyrosine kinase and its ligands play a crucial role in cell proliferation, survival, migration, and angiogenesis. Aberrant MET signaling is implicated in the development and progression of numerous cancers, including lung, gastric, and breast cancers. Consequently, MET kinase inhibitors are a focal point in targeted cancer therapy research. The specific inhibitor with CAS 1025720-94-8 is lauded for its high selectivity towards MET family members like Axl, Ron, and Tyro3, coupled with strong in vitro and in vivo efficacy, as evidenced by extensive scientific literature. This precision is vital for minimizing off-target effects and achieving robust experimental results.
Why Choose a Chinese Manufacturer for Your Supply Needs?
When seeking to buy high-purity MET kinase inhibitors, partnering with a reputable manufacturer in China offers several distinct advantages. Firstly, Chinese manufacturers have established themselves as leaders in the production of fine chemicals and pharmaceutical intermediates, boasting advanced synthesis capabilities and stringent quality control processes. This ensures that you can purchase a product with a guaranteed purity, often exceeding 98% as verified by HPLC, which is critical for the reproducibility of your research.
Secondly, the competitive landscape in China often translates to favorable pricing. Researchers looking to purchase MET kinase inhibitors for preclinical studies or larger research projects can benefit from competitive price points, making advanced research more accessible. By working directly with a manufacturer or a trusted supplier, you can often negotiate better terms and ensure a stable supply chain, which is crucial for ongoing research projects.
Key Considerations When Sourcing MET Kinase Inhibitors
When you search for a MET kinase inhibitor supplier or manufacturer, consider the following:
In conclusion, sourcing high-quality MET kinase inhibitors like the one identified by CAS 1025720-94-8 requires careful consideration. By prioritizing purity, documented efficacy, and a reliable supply chain from a reputable Chinese manufacturer and supplier, researchers can equip themselves with the essential tools needed to drive innovation in cancer therapy and signal transduction research. We invite you to contact us to discuss your specific research needs and explore how our products can support your next breakthrough.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.